Markers of preeclampsia and the relationship to cardiovascular disease: review of the twenty-first century literature (Q37748773)

22 August 2017

1 reference

title

Markers of preeclampsia and the relationship to cardiovascular disease: review of the twenty-first century literature (English)

1 reference

22 August 2017

0 references

cardiovascular disease

1 reference

Mary Downes Gastrich

1 reference

22 August 2017

Revitale Faro

series ordinal

1 reference

22 August 2017

Todd Rosen

series ordinal

1 reference

22 August 2017

publication date

1 August 2010

1 reference

Journal of Maternal-Fetal and Neonatal Medicine

22 August 2017

published in

1 reference

22 August 2017

1 reference

22 August 2017

1 reference

22 August 2017

page(s)

751-769

1 reference

Placentation abnormalities in the pathophysiology of preeclampsia

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

The global impact of pre-eclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Advances in the understanding of eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

What we have learned about preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Long-term renal function after HELLP syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Pathophysiology of the clinical manifestations of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

New aspects in the pathophysiology of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Cardiovascular sequelae of toxaemia of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

World Health Organization systematic review of screening tests for preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Angiogenesis in implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Latest advances in understanding preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Association of maternal endothelial dysfunction with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

An Australian twin study of the genetic basis of preeclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Microvascular dysfunction: a link between pre‐eclampsia and maternal coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Cardiovascular and thromboembolic events following hypertensive pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Molecular mechanisms of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Implantation and the placenta: key pieces of the development puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Soluble endoglin as a second-trimester marker for preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Serum levels of angiopoietin-related growth factor are increased in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Proteomics to study genes and genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

First trimester markers for pre-eclampsia: placental vs. non-placental protein serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Potential biomarkers of preeclampsia: inverse correlation between hydrogen peroxide and nitric oxide early in maternal circulation and at term in placenta of women with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

A longitudinal study of biochemical variables in women at risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Urinary Placental Growth Factor and Risk of Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

Risk for subsequent coronary artery disease after preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2010.481316

10.3109/14767058.2010.481316

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference